Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
18. December 2025
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16093
Articles 1 - 20 / 321844
The role of gut microbiota in breast cancer: biomarker identification and therapeutic applications.
Antonie Van Leeuwenhoek
Abrishami M, Sabouri M, Joneidi F, Haghshenas Z, Khalili-Tanha G, Nazari E.
PMID: 41408007 [PubMed - indexed for MEDLINE]
Age as a determining factor in decision-making in older patients with HER2-positive and triple-negative breast cancer.
Eur Geriatr Med
Otero-Romero D, Medina-Mora L, Carramiñana-Nuño R, Arribas-Del-Amo D.
PMID: 41407992 [PubMed - as supplied by publisher]
Revised: Exploring the experiences and perceived impact of using digital health technologies on individualised care among breast cancer survivors in the first year after primary treatment for breast cancer: a qualitative study.
Support Care Cancer
I, Seyhan .
PMID: 41407978 [PubMed - indexed for MEDLINE]
Characterization of ficus hispida fruit extract and assessment of Gallic acid using in Silico and in vitro studies against breast cancer.
Sci Rep
Prakash JM, Badr-Eldin SM, Aldawsari HM, Kotta S, Kolli D.
PMID: 41407830 [PubMed - as supplied by publisher]
Women's perspectives on integrating artificial intelligence in breast cancer screening services in Abu Dhabi, united Arab Emirates.
Sci Rep
Elhadi YAM, Abdullahi AS, Shamsi AA, Althehli A, Alzaabi H, Al Ali H, Alnaqbi M, Alkindi S, Alhashmi S, Razouk H, Al Ameri M, Rahma AT.
PMID: 41407797 [PubMed - as supplied by publisher]
ER degradation for ER(+)/HER2- advanced or metastatic breast cancer: a phase 1 trial.
Nat Commun
Hamilton E, Layman RM, Cosgrove D, Danso M, Zhang H, He W, Kim SY, Fan J, Patel MR.
PMID: 41407710 [PubMed - as supplied by publisher]
ARTIA-Cervix: a prospective trial of adaptive radiation therapy for cervical cancer.
Int J Gynecol Cancer
Mayadev JS, Albuquerque KV, Price JG, Marcrom S, Hrycushko BA, Horwitz EM, Panetta J, Stanley DN, Samanta S, Sabouri P, Liu PY, Kohlmyer S, McCann C, Russell K, Moore KL, Ray X.
PMID: 41407635 [PubMed - as supplied by publisher]
Benign tumour of the vulva: vulvar schwannoma.
BMJ Case Rep
Kwek M, Chang HY, Namuduri PR.
PMID: 41407498 [PubMed - indexed for MEDLINE]
Human papillomavirus vaccine uptake and associated factors among in-school adolescent girls in Harari regional state, Eastern Ethiopia: a cross-sectional study.
BMJ Open
Tesfaye H, Mezmur H, Ahmed N, Tesfaye G, Semahegn A.
PMID: 41407427 [PubMed - indexed for MEDLINE]
Pilot randomised controlled trial of the self-help plus stress management intervention among patients with breast and gynaecological cancer in Viet Nam: a study protocol.
BMJ Open
Le PD, Nguyen NB, Dang ATT, Tran LTK, Pham HN, Le TA, Vo KV, Nguyen HT, Hoang DT, Phan DC, Nguyen CBT, Nguyen MHT, Nguyen QH, Phan HNT, Dang TQ, Nguyen HT, Le DD, Phan THT, Nguyen PTN, Nguyen VT, Tran PT, Pham AN, Vom Eigen K, Campbell R, Taylor C, Tran HTT, Hoang MV.
PMID: 41407411 [PubMed - indexed for MEDLINE]
A cluster randomised controlled trial to test the effectiveness and cost-effectiveness of a self-management intervention to support women with breast cancer to return to work: A study protocol.
Contemp Clin Trials
Pallin ND, Algeo N, O'Connor ME, Connolly H, Lowry M, Bennett K, Gillespie P, Hobbins A, Gallagher P, Mullen L, Lyons KD, McHugh SM, Connolly D.
PMID: 41407101 [PubMed - as supplied by publisher]
Exploration of precise classification and therapeutic targets of breast cancer based on genes related to neuro-cancer crosstalk.
Transl Oncol
Li Z, Sun C, Cui Y, Huang Y, Liu M, Xie H, Wang S.
PMID: 41406890 [PubMed - as supplied by publisher]
The role of nipple-areola complex tattooing in breast cancer psycho-physical rehabilitation: An updated review.
Cancer Treat Res Commun
Maselli D, Torreggiani M, Soffientini V, Tamagnini E, Botti S, Ferri P, Costi S.
PMID: 41406865 [PubMed - as supplied by publisher]
Understanding female breast cancer risk in the Indian population: Evidence from a systematic review and meta-analysis.
Cancer Epidemiol
Vijayakumar S, Ramamoorthy T, George AD, Nath A.
PMID: 41406686 [PubMed - as supplied by publisher]
Predictive Value of RDW and RCI Indices in Pulmonary Embolism: Insights from Breast Cancer, Lung Cancer, and Non-Cancer Patients.
Clin Appl Thromb Hemost
Duvenci Birben O, Akkurt ES, Cokelik SB, Yenibertiz D.
PMID: 41406072 [PubMed - indexed for MEDLINE]
Disparities in cardiometabolic and cardiovascular risk after breast cancer: the pathways heart study.
JNCI Cancer Spectr
Diaz AE, Kwan ML, Laurent CA, Rillamas-Sun E, Roh JM, Iribarren C, Rana JS, Kushi LH, Reding KW, Quesenberry CP, Greenlee H, Cheng RK.
PMID: 41405835 [PubMed - as supplied by publisher]
Early-phase semi-quantitative analysis versus full time-course quantitative modeling of ultrafast dynamic contrast-enhanced MRI for breast cancer diagnosis, molecular subtyping, and treatment response prediction.
Insights Imaging
Cao Y, Gong X, Huang Y, Chen H, Fang J, Wang L, Li L, Tang S, Yin T, Wang X, Zhang J.
PMID: 41405789 [PubMed]
Quality of care before and after initial certification at a German certified hereditary breast and ovarian cancer center.
J Cancer Res Clin Oncol
Amann N, Hörner M, Spannring H, Brückner L, Gocke J, Müller C, Boesl C, Bader S, Heindl F, Hack CC, Fasching PA, Beckmann MW, Krückel A.
PMID: 41405720 [PubMed - indexed for MEDLINE]
Contrast-enhanced mammography-guided biopsy in a prone position in the diagnosis of breast cancer: technical parameters and clinical outcomes.
Insights Imaging
Morano G, Cicciarelli F, Moffa G, Bonito G, Rizzo V, Calabrese A, Galati F, Pediconi F.
PMID: 41405665 [PubMed]
KEYLYNK-009: Pembrolizumab Plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer and Clinical Benefit From First-Line Pembrolizumab Plus Chemotherapy.
Clin Cancer Res
Rugo HS, Cescon DW, Robson ME, Im SA, Dalenc F, Yañez Ruiz E, Reyes-Cosmelli F, Walshe JM, Im YH, Kulyk S, Dudnichenko O, Llinás-Quintero N, Saji S, Miyoshi Y, Bardia A, Harbeck N, Haiderali A, Fan L, Mejia JA, Karantza V, Llombart-Cussac A.
PMID: 41405563 [PubMed - as supplied by publisher]
Articles 1 - 20 / 321844
Page 1 of 16093
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy